- PersonaGene Genetic Panels
- L-asparaginase Assay for Leukemia Patients
- U-Swab Genital Pathogen Testing
- KRAS-BRAF Testing for Colorectal Cancer Mutations
The most complete genetic panel for cardiology.
Our Cardiology Panel identifies drug metabolism ability for beta blockers, Plavix and Warfarin as well as evaluates cardiovascular disease risk.
We can help you commercialize your ELISA diagnostic
Our staff is qualified to help commercialize your ELISA diagnostic or to develop and validate ELISAs for your specific purpose.
The UroloGene Panel can help personalize his dose.
The UroloGene Panel can provide important information about how a patient metabolizes drugs to help prevent harmful side effects and drug interactions.
Protein, peptide and immunochemistry services.
We provide consultative oriented services for the isolation, analysis, characterization and production of proteins and peptides.
A new laboratory derived test to measure effectiveness of treatment in leukemia patients.
The L-asparaginase activity test can help identify patients experiencing “silent inactivation” and ensure that adequate asparaginase activity is present.
AIBioTech is a unique combination of diagnostic laboratory and comprehensive contract research organization. Based on over 20 years of experience with DNA sequencing, assay development and practical research applications, AIBioTech provides clinical testing services and research and development services to physicians and life science investigators in clinical practices; biotechnology and pharmaceutical companies; academic institutions and in several different government agencies
Our scientists are serious researchers who work with top pharmaceutical; biotechnology; and research and development companies to help bring their products from discovery to market. They also develop innovative clinical assays using the latest DNA sequencing technologies to provide clinical testing to physicians and patients.
AIBioTech laboratories are certified by the College of American Pathologists (CAP) and the Clinical Laboratory Improvements Association (CLIA). Contract research services are offered individually or can be integrated to support product development from discovery to market with full regulatory support under FDA GLP Guidelines 21 CFR 58.